3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase NA
5
Phase 4
3
Phase 3
1
Phase 1
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
145
Colorectal Neoplasms
97
Carcinoma, Non-Small-Cell Lung
97
Carcinoma, Hepatocellular
69
Stomach Neoplasms
65
Rectal Neoplasms
54
Neoplasms
53
Lung Neoplasms
44
Prostatic Neoplasms
41
Colonic Neoplasms
41
Leukemia, Myeloid, Acute
40
Nasopharyngeal Carcinoma
39
Lymphoma, Large B-Cell, Diffuse
39
Uterine Cervical Neoplasms
37
Neoplasm Metastasis
33
Esophageal Neoplasms
33
Ovarian Neoplasms
32
Multiple Myeloma
31
Lymphoma
31
Lymphoma, Follicular
30
Leukemia
28
Pancreatic Neoplasms
27
Recurrence
23
Head and Neck Neoplasms
22
Brain Neoplasms
21
Urinary Bladder Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Non-Hodgkin
19
Lymphoma, Mantle-Cell
18
Squamous Cell Carcinoma of Head and Neck
17
Interventions
paclitaxel-Angiopep-2 conjugate
1
eribulin
1
Methotrexate
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Unknown
×
Meningeal Carcinomatosis
×
Clear all
NCT03613181
2023-04-24
ANGLeD
Angiochem Inc
Phase 3
Unknown
150 enrolled